BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2003
View Archived Issues
EPI-4067: multitargeting antisense oligonucleotide for the treatment of allergic disease and asthma
Read More
New anticoccidial agents from fungal origin presented by Meiji Seika and Mitsubishi Chemical
Read More
Neurocrine Biosciences identifies novel GnRH antagonists
Read More
Nociceptin receptor agonists identified by Banyu researchers
Read More
Nikken Chemicals presents new antiasthmatic compound with dual mechanism
Read More
Novel nicotinic receptor modulators and their use as peripheral analgesics
Read More
Pyrazole ERK/Akt kinase inhibitors prepared and tested at Vertex
Read More
Merck scientists describe tissue-selective androgen receptor modulators for bone disorders
Read More
New androgen receptor modulators and their use in age-related conditions reported by BMS
Read More
NSAIDs shown to bind to beta-amyloid senile plaques in vitro
Read More
SR-13668 selected by NCI for RAPID program
Read More
P57 program progresses at Pfizer
Read More
Romark launches Alinia for children in U.S.
Read More
Phase II Alista trial begins recruitment
Read More
FDA approves expanded label for Betaseron; ABOVE trial explores increased dose and frequency
Read More
Phase III decitabine study in MDS completes patient enrollment
Read More
Results reported for phase III trial of Affinitak in NSCLC
Read More
H3 Pharma licenses SC-1 from OncoMab
Read More
Further analysis of DIAMOND study data reported
Read More
Phase I IND for AVP-13358 cleared
Read More
Dual erbB-2/EGFR tyrosine kinase inhibitor with promising preclinical profile
Read More
Toxicity of LE-SN-38 in dogs after repeated i.v. doses
Read More
Acute and subchronic toxicity testing conducted on CJC-1131 in rats and dogs
Read More
Calmodulin antagonist DY-9760e improves brain edema by inhibiting enhanced BBB permeability
Read More
One course of AIC immunotherapy lasts through two allergy seasons according to phase II data
Read More